Tango Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TRV GP IV, LLC | 02/13/2025 | 16.86 M | $52.09 M | 0.00% | 15.54% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 10.74 M | $33.17 M | 100.00% | 9.89% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 10.63 M | $32.85 M | -20.25% | 9.80% |
| 02/14/2025 | 10.38 M | $32.08 M | 100.00% | 9.57% | |
| NEXTECH INVEST LTD. | 02/14/2025 | 5.53 M | $17.10 M | 0.00% | 5.10% |
| GILEAD SCIENCES, INC. | 02/13/2025 | 4.85 M | $15.00 M | 100.00% | 4.47% |
| BLACKROCK, INC. | 02/07/2025 | 4.38 M | $13.53 M | 0.39% | 4.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 4.00 M | $12.36 M | 100.00% | 3.69% |
| VANGUARD GROUP INC | 02/11/2025 | 3.99 M | $12.31 M | 9.32% | 3.67% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 3.35 M | $10.34 M | -33.40% | 3.08% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 3.28 M | $10.13 M | 22.03% | 3.02% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.80 M | $8.67 M | 100.00% | 2.58% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 2.71 M | $8.38 M | 0.00% | 2.50% |
| SIREN, L.L.C. | 02/14/2025 | 2.60 M | $8.05 M | 0.00% | 2.40% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 1.73 M | $5.35 M | 100.00% | 1.60% |
| CITADEL ADVISORS LLC | 02/14/2025 | 1.63 M | $5.03 M | -39.62% | 1.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.39 M | $4.29 M | 1.33% | 1.28% |
| STATE STREET CORP | 02/14/2025 | 1.23 M | $3.80 M | -46.89% | 1.13% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 1.19 M | $3.67 M | 0.00% | 1.10% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 708,385 | $2.19 M | 0.00% | 0.65% |
| BESSEMER GROUP INC | 02/13/2025 | 708,384 | $2.19 M | 0.00% | 0.65% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 662,776 | $2.05 M | 83.75% | 0.61% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 655,158 | $2.03 M | 100.00% | 0.60% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 630,000 | $1.95 M | 0.00% | 0.58% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 550,000 | $1.70 M | 100.00% | 0.51% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 517,426 | $1.60 M | 100.00% | 0.48% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 513,429 | $1.59 M | 5.38% | 0.47% |
| NORTHERN TRUST CORP | 02/14/2025 | 513,079 | $1.59 M | 7.06% | 0.47% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 495,106 | $1.53 M | 100.00% | 0.46% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 486,888 | $1.50 M | -10.42% | 0.45% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 474,955 | $1.47 M | -20.72% | 0.44% |
| UBS GROUP AG | 02/14/2025 | 414,473 | $1.28 M | -5.98% | 0.38% |
| WOODLINE PARTNERS LP | 02/14/2025 | 394,397 | $1.22 M | 100.00% | 0.36% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 347,271 | $1.07 M | 100.00% | 0.32% |
| MORGAN STANLEY | 02/14/2025 | 320,070 | $989,016 | -6.41% | 0.30% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 287,052 | $886,991 | 101.33% | 0.26% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 272,233 | $841,200 | 55.23% | 0.25% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 249,646 | $771,406 | 100.00% | 0.23% |
| CONGRESS ASSET MANAGEMENT CO /MA | 01/30/2025 | 227,989 | $704,486 | 9.05% | 0.21% |
| TRV GP VI, LLC | 02/13/2025 | 194,174 | $599,998 | 100.00% | 0.18% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 192,259 | $594,080 | -6.13% | 0.18% |
| ALGERT GLOBAL LLC | 02/14/2025 | 162,300 | $502,000 | 100.00% | 0.15% |
| FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 154,947 | $478,786 | 0.00% | 0.14% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 138,247 | $427,183 | -3.46% | 0.13% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 126,553 | $391,049 | 670.40% | 0.12% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 121,993 | $377,000 | 100.00% | 0.11% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 114,827 | $354,815 | 100.00% | 0.11% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 110,448 | $341,284 | 12.37% | 0.10% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 103,020 | $318,331 | -7.80% | 0.09% |
| PDT PARTNERS, LLC | 02/14/2025 | 102,807 | $317,674 | 100.00% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tango Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 155 institutional investors and hedge funds held shares of Tango Therapeutics, Inc.. The most heavily invested institutionals were:
ROTHSCHILD INVESTMENT LLC: 0
TRV GP IV, LLC: 16.86 M
TCG Crossover Management, LLC: 10.74 M
EcoR1 Capital, LLC: 10.63 M
Nextech Invest Ltd.: 5.53 M
GILEAD SCIENCES, INC.: 4.85 M
98.10% of Tango Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 108.30 M shares in the last 24 months. This purchase volume represents approximately $152.70 M in transactions.